Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats

Diabetologia Croatica

Volumn 39, Issue 1, 2010, Pages 15-35

  Ahmed, Osama Mohamed ^a   Moneim, Adel Abdel ^a   Yazid, Ibrahim Abul ^b   Mahmoud, Ayman Moawad ^a  

^a Beni Suef University   (Egypt)

^b NUCLEAR RESEARCH CENTER   (Egypt)

Author keywords

Nicotinamide streptozotocin induced diabetic rats; Ruta graveolens infusion; Rutin

Indexed keywords

C PEPTIDE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN PHOSPHORYLASE; HEXOKINASE; INSULIN; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; RUTA GRAVEOLENS EXTRACT; RUTOSIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID ABSORPTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES;

EID: 77951229157     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. In: Report of a WHO Consultation, Part 1: Diagnosis and classification of diabetes mellitus. WHO/NCD/ NCS/99.2, Geneva, 1999.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
3. Cheng D. Prevalence, predisposition and prevention of type II diabetes. Nutr Metab 2005;2:2-29.
4. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007;125:451-472.
5. Rosenson RS. Effects of peroxisome proliferator activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus. Am J Cardiol 2007; 99 (Suppl): 96B-104B.
6. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126(4):789-799.
7. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000;16:145-171.
8. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. A nuclear receptor atlas: macrophage activation. Mol Endocrinol 2005;19(10):2466-2477.
9. Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276(41):37731-37734.
10. Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA. Halofenate is a selective peroxisome proliferatoractivated receptor gamma modulator with antidiabetic activity. Diabetes 2006;55(9):2523-2533.
11. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000;19:4046-4055.
12. Kim KH, Lee K, Moon YS, Sul HS. A cysteinerich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252-11256.
13. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistinlike molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003;111:225-230.
14. Ayyanar M, Sankarasivaraman K, Ignacimuthu S. Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in South Tamil Nadu, India. Ethnobotanical Leaflets 2008;12:276-280.
15. Arulrayan N, Rangasamy S, James E, Pitchai D. A database for medicinal plants used in the treatment of diabetes and its secondary complications. Bioinformation 2007;2(1):22-23.
16. Raghav SK, Gupta B, Agrawal C, Goswami K, Das HR. Anti-inflammatory effect of R. graveolens L. in murine macrophage cells. J Ethnopharmacol 2006;104:234-239.
17. Pathak S, Multani AS, Banerji P, Banerji P. Ruta selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 2003;23:975-982.
18. CSIR. In: Chadha YR, editor. The Wealth of India - A dictionary of Indian raw materials and industrial products, Vol. IX. Publications and Information Directorate, Council of Scienti?c and Industrial Research, India, 1988; pp. 95-96.
19. Hertog MG, Hollman PC, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chemist 1992;40:2379-2383.
20. Hertog MG, Feskens EJ, Hollmann PC, Katan MB, Kronthout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993;342:1007-1011.
21. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993;20:21-29.
22. Chu YH, Chang CL, Hsu HF. Flavonoid content of several vegetables and their antioxidant activity. J Sci Food Agric 2000;80:561-566.
23. Kamalakkannan N, Prince SM. Antihyperglycemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin Pharmacol Toxicol 2006;98(1):97-103.
24. Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 2003;417:12-17.
25. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-1148.
26. Janbaz KH, Saeed SA, Gilani AH. Protective effect of rutin on paracetamol-and CCl4-induced hepatotoxicity in rodents. Fitoterapia 2002;73:557-563.
27. Canadian Council on Animal Care. Guide to the care and use of experimental animals. Vol. 2, CCAC, Ottawa, Ontario, Canada, 1993.
28. Swanston-Flatt SK, Day C, Flatt PR, Bailey CJ. Evaluation of antihyperglycemic properties of traditional plant treatment for diabetes in streptozotocin diabetic and db/db mice. In: Shafrir E, editor. Frontiers in diabetes research. Lessons from animal diabetes. Vol. 3. London: Smith-Gordon, 1995; pp. 286-293.
29. Claus FD. Phamacognosy, 4th edition. London: Henry Kumpton, 1961.
30. Punitha IS, Shirwaikar A, Shirwaikar A. Antidiabetic activity of benzyl tetra isoquinoline alkaloid berberine in streptozotocin-nicotinamide induced type 2 diabetic rats. Diabetol Croat 2005;34(4):117-128.
31. Bancroft JD, Stevens A. Theory and practice of histological techniques, 2nd edition. Edinburgh: Churchill Livingstone, 1982; pp. 374-375.
32. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-27.
33. Baker JR, Metcalf PA, Holdway I, Johnson RN. Serum fructosamine concentration as a measure of blood glucose control in type 1 (insulin dependent) diabetes. Br Med J 1985;290:352-355.
34. Marschner I, Bottermann P, Erhardt F, Linke R, Maier V, Schwandt P, Vogt W, Scriba PC. Group experiments on the radio-immunological insulin determination. Horm Metab Res 1974;6:293-296.
35. Bonser A, Garcia-Webb P. C-peptide measurement: methods and clinical utility. CRC Crit Rev Clin Lab Sci 1984;19:279-352.
36. Seifter S, Dayton S, Novic B, Muntwyler E. The estimation of glycogen with anthrone reagent. Arch Biochem 1950;25:191-200.
37. Branstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissues in individuals of various ages. J Gerontol 1963;238:3280.
38. Begum N, Sam GP, Shanmugasundaram KR. Serum enzymes in human and experimental diabetes mellitus. Indian J Med Res 1978;68:774-784.
39. Stallman W, Hers HG. The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note of the specific determination of the a and b forms of liver glycogen phosphorylase. Eur J Biochem 1975;54:341-350.
40. Munoz MA, Balon M, Fernandez C. Direct determination of inorganic phosphorus in serum with a single reagent. Clin Chem 1983;29:372-374.
41. Frings CS, Frendley TW, Dunn RT, Queen CA. Improved determination of serum total lipids by the sulpho-phospho-vanillin reaction. Clin Chem 1972;18(7):673-674.
42. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28(1):2077-2080.
43. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20(4):470-475.
44. Burnstein M, Selvenick HR, Morfin R. Rapid method for isolation of lipoprotein from human serum with polyanions. J Lipid Res 1970;11:583-395.
45. Venugopala Rao A, Ramakrishan S. Indirect assessment of hydroxymethylglutaryl CoA reductase (NADPH) activity in liver tissue. Clin Chem 1975;21(10):1523-1525.
46. Friedewald WT. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18(7):499-502.
47. Nobert WT. Clinical guide to laboratory tests, 3rd edition. Philadelphia: W.B. Saunders Company, 1995.
48. Preuss HG, Jarrel ST, Scheckenbach R, Lieberman S, Anderson RA. Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 1998;17(2):116-123.
49. Beutler E, Duron O, Kelly BM. Improved method for determination of blood glutathione. J Lab Clin Med 1963;61:882-888.
50. Koster JF, Biermond P, Swaak AJG. Intracellular and extracellular sulph-hydryl levels in rheumatoid arthritis. Ann Rheum Dis 1986;45:44-46.
51. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970;34:30-38.
52. Kar M, Mishra D. Catalase, peroxidase and polyphenoloxidase activities during rice leaf senescence. Plant Physiol 1976;57:315-319.
53. Howell SL, Taylor KW. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J 1968;108:17-24.
54. Morgan NG, Montague W. Stimulation of insulin secretion from isolated rat islets of Langerhans by melittin. Biosci Rep 1984;4:665-671.
55. Zarzuelo A, Risco S, Gamez MJ, Jimenez J, Camara M, Martinez MA. Hypoglycemic action of Salvia lavandulifolia vahl. ssp. Oxyodon: a contribution to studies on the mechanism of action. Life Sci 1990;47:909-915.
56. Otto P, Kephart D, Bitner R, Huber S, Volkerding K. Separate isolation of genomic DNA and total RNA from single samples using the SV Total RNA Isolation System. Promega Notes 1998;69:19-23.
57. Roa M, Blane K, Zonneberg M. One way analysis of variance. Version IA (C). PC-STAT, Program coded by University of Georgia, USA, 1985.
58. Chakravarthy BK, Gupta S, Gode KD. Antidiabetic effect of (-)-epicatechin. Lancet 1982;1:272-273.
59. Chakravarthy BK, Gupta S, Gode KD. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci 1982;31:2693-2697.
60. Nuraliev IN, Avezov GA. The efficacy of quercetin in alloxan diabetes. Exp Clin Pharmacol 1992;55:42-44.
61. Vessal M, Zal F, Vasi M. Effects of Teucrium polium on oral glucose tolerance test, regeneration of pancreatic islets and activity of hepatic glucokinase in diabetic rats. Arch Iran Med 2003;6:36-39.
62. Atta-Ur-Rahman, Zaman K. Medicinal plants with hypoglycemic activity. J Ethnopharmacol 1989;26:1-55.
63. Chattopadhyay RR, Sarkar SK, Ganguly S, Banerjee RN, Basu TK. Hypoglycemic and antihyperglycemic effect of leaves of Vinca rosea. Indian J Physiol Pharmacol 1991;35(3):145-151.
64. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995;2(2):137-189.
65. Essawy GS, Sobbhy HM, El-Banna HA. The hypoglycemic effect of volatile oil of some Egyptian plants. Vet Med J (Giza) 1995;43(2):167-172.
66. Akhani SP, Vishwakarma SL, Goyal RK. Antidiabetic activity of Zingiber officinale in streptozotocin-induced type 1 diabetic rats. J Pharm Pharmacol 2004;56(1):101-105.
67. Liao K, Yin M. Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: importance of the partition coefficient. J Agric Food Chem 2000;48:2266-2270.
68. Coskun OM, Kanter A, Korkmaz, SO. Quercetin, a flavonoid antoxidant, prevents and protects streptozotocin induced oxidative stress and a-cell damage in rat pancreas. Pharmacol Res 2005;51:117-123.
69. Hii CST, Howell SL. Effects of flavonoids on insulin secretion and Ca+2 handling in rat islets of Langerhans. J Endocrinol 1985;107:1-8.
70. Hindle EJ, Rostron GM, Clarck SA, Catt JA. Serum fructosamine and glycated hemoglobin measurements in diabetic control. Arch Dis Childhood 1986;61:113-117.
71. Donnelly JG. Carbohydrates and alterations in glucose metabolism. In: Bishop ML, Fody EP, editors. Clinical chemistry (principles, procedures, correlations). Philadelphia: Lippincott, 1996; pp. 308-309.
72. Elgawish A, Glomb M, Freelander M, Monnier VM. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 1996;271:12964-12971.
73. Grover JK, Vats V, Rathi SS. Antihyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 2000;73:461-470.
74. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reserving the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001;224(1-2):45-51.
75. Lavoie L, Van de Werve G. Hormone-stimulated glucose production from glycogen in hepatocytes from streptozotocin diabetic rats. Metabolism 1991;40(10):1031-1036.
76. Ahmed OM. The hypoglycemic effect of curcumin and esculetin and their probable mechanisms of action in streptozotocin diabetic albino rats. J Egypt Ger Soc Zool 2005;46(A):351-375.
77. Abdel-Moneim A, Ahmed OM, Rawi SM, Semmler M. Studies on the hypoglycemic and hypolipidemic effects of glimepiride and some antidiabetic plants on streptozotocin diabetic rats. J Egypt Ger Soc Zool 2001;34(A):175-206.
78. Ahmed OM. Evaluation of the antihyperglycemic, antihyperlipidemic and myocardial enhancing properties of pioglitazone in diabetic and hyperthyroid rats. J Egypt Ger Soc Zool 2006;51(A):253-278.
79. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31.
80. Cadefau J, Bollen M, Stalmans W. Glucoseinduced glycogenesis in the liver involves the glucose-6-phosphate-dependent phosphorylation of glycogen synthase. Biochem J 1997;322(3):745-750.
81. Bahr M, Von Holty M, Muller G, Eckel J. Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride. Endocrinology 1995;136:2547-2553.
82. Muller G, Satoh Y, Geisen K. Extrapancreatic effects of sulfonylureas - a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract 1995;28(Suppl):115-137.
83. Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S. A natural protective mechanism against hyperglycemia in vascular endothelial and smooth muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J 2002;362:413-422.
84. Raz I, Eldor R, Cernea S, Shafrir E. Diabetes, insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 2005;21:3-14.
85. Jung UJ, Lee MK, Park YB, Kang MA., Choia MS. Effect of citrus? Avonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 2006;38:1134-1145.
86. Park SY, Bok SH, Jeon SM, Park YB, Lee SJ, Jeong TS, Choi MS. Effect of rutin and tannic acid supplements on cholesterol metabolism in rats. Nutr Res 2002;22:283-295.
87. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003;144:2201-2207.
88. Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005;54:2460-2470.
89. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 2006;45:120-159.
90. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006;116:571-580.
91. Fulgencio JP, Kohl C, Girard J, Pegorier JP. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes 1995;45:1556-1562.
92. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K. The mechanisms by which both heterozygous peroxisome proliferatoractivated receptor gamma (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 2001;276:41245-41254.
93. Kim SY, Kim HI, Park SK, Im SS, Li T, Cheon HG. Liver glucokinase can be activated by peroxisome proliferator-activated receptor-γ. Diabetes 2004;53:S66-S70.
94. Shiomi M, Ito T, Tsukada T, Tsujita Y, Horikoshi H. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis in WHHL rabbits. Atherosclerosis 1999;142:345-353.
95. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000;43:527-550.
96. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific PPARγ deletion causes insulin resistance. Nat Med 2003;9:1491-1497.
97. Anandharajan R, Pathmanathan K, Shankernarayanan NP, Ram AV, Arun B. Upregulation of GLUT-4 and PPARγ by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action. J Ethnopharmacol 2005;97:253-260.
98. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diab Metabol 2008;34:2-11.
99. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.